Remove Doctors Remove Hormones Remove Nurses Remove Research
article thumbnail

Heart Palpitations Can Be Common During Menopause

The Pharma Data

New research shows that the palpitations are a distressing problem for roughly 25% of women during menopause, but those feelings of a pounding heart or skipped heartbeat have been the subject of very little research, said study author Janet Carpenter. So often you will see them anecdotally go away when we put women on hormone therapy.”

article thumbnail

Unblock My Hormones And Start Burning Fat TODAY With HB5

The Pharma Data

Product Name: Unblock My Hormones And Start Burning Fat TODAY With HB5. Click here to get Unblock My Hormones And Start Burning Fat TODAY With HB5 at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Trans Healthcare: How Pharma Marketers Can Positively Impact This Underserved Community

Intouch Solutions

It, like the Nightingale Pledge for nurses, is a list of tenets that physicians abide by to uphold certain morals and to ensure healthcare professionals (HCPs) provide top-quality care to all who seek it. “I For trans individuals, years may pass between doctor visits because of the emotional and financial tolls that can accompany them.

article thumbnail

Biotox Gold

The Pharma Data

If you’re on the fence about all this I get it, but it really does work and everything Tonya says is backed up by science and research, take it from a skeptic! Addressing this fat resistant hormone is the single most important thing you can do right now for long-lasting results now and into old age.

article thumbnail

CAPTIVATE Study Shows an IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Chemotherapy-Free Combination Has Potential to Provide Remission After Fixed-Duration Treatment for Chronic Lymphocytic Leukemia (CLL)

The Pharma Data

Call your doctor for medical advice about side effects. Together, the companies are committed to BCL-2 research and to studying venetoclax in clinical trials across several blood cancers. Call your doctor for medical advice about side effects. . Advise nursing women to discontinue breastfeeding during treatment.

article thumbnail

CarboFix

The Pharma Data

Plus, I’m going to show you all the research…. All the scientific studies… And the words straight from a doctor’s mouth… So you’ll have everything you need… By the way, my name is Matt Stirling. After stumbling upon this new breakthrough scientific research…. Which is your #1 fat-storing hormone.

article thumbnail

IMBRUVICA® (ibrutinib) Plus VENCLEXTA®/VENCLYXTO® (venetoclax) Combination Shows Superior Progression-Free Survival Compared to Chlorambucil Plus Obinutuzumab in First-line Chronic Lymphocytic Leukemia (CLL) Phase 3 GLOW Study

The Pharma Data

“With CLL being one of the most common types of blood cancer, the expansion of research into additional treatment options for patients is an important clinical undertaking,” said Arnon Kater , M.D., Together, the companies are committed to BCL-2 research and to studying venetoclax in clinical trials across several blood cancers.